Trials / Completed
CompletedNCT00067444
Depression Study In Elderly Patients
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Evaluating the Efficacy and Safety of Paroxetine CR in Elderly Outpatients Diagnosed With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 560 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Major Depressive Disorder (MDD) Study in Elderly Outpatients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine CR |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2005-01-01
- Completion
- 2005-01-01
- First posted
- 2003-08-21
- Last updated
- 2016-09-01
Locations
46 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00067444. Inclusion in this directory is not an endorsement.